Clinical Trial Update: A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated a sildenafil-loaded nanocarrier formulation for alopecia areata, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Assiut University | Conditions: Alopecia Areata | EARLY_Phase 1 | Status: COMPLETED